Thibaud V.
- Country
- France
- Department
- Medical Oncology
Research Overview
- Evaluation of HDM201 and Pazopanib in P53 Wild-Type Advanced/Metastatic Soft Tissue Sarcomas
- Phase I Evaluation of MEDI5752 Combined with Stereotactic Radiotherapy in Metastatic Soft Tissue Sarcoma Patients
- Randomized Phase II/III Study of Cabozantinib Maintenance Versus Best Supportive Care in Osteosarcoma Patients After First‑Line Chemotherapy (FOSTER‑CabOS)
Data & Insights
Has run more than one trial at 91 of 167 partner sites.
Specializations
Bone Sarcomas
This investigator specializes in treating various forms of bone sarcomas, with particular focus on high-grade osteosarcoma in different age groups. Their research encompasses both localized and metastatic disease states.
- High-risk osteosarcoma treatment protocols
- Maintenance therapy approaches
- Conventional chondrosarcoma management
The investigator explores novel therapeutic combinations including immunotherapy and targeted agents for bone sarcomas.
Soft Tissue Sarcomas
The investigator conducts research in advanced soft tissue sarcomas, including specific subtypes such as leiomyosarcoma and liposarcoma. Their work includes evaluation of various treatment approaches for both localized and metastatic disease.
- Molecular profiling applications
- Immunotherapy combinations
- Novel therapeutic strategies
Their research extends to perioperative treatment optimization and targeted therapy development.
Gastrointestinal Stromal Tumors
The investigator focuses on treating advanced gastrointestinal stromal tumors (GIST), particularly in cases where standard treatments have failed. Their research explores innovative combination approaches.
- Treatment resistance management
- Targeted therapy combinations
- Advanced disease protocols
Their work includes evaluation of novel therapeutic strategies for unresectable and metastatic GIST.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.